NTRA.NASDAQNatera, INC

Form 4: Natera Co-Founder Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Natera Co-Founder Jonathan Sheena sold 4,000 shares of common stock for approximately $800,273.60 through a pre-arranged 10b5-1 trading plan.

Summary

  • Jonathan Sheena, a Director and Co-Founder of Natera, Inc. (NTRA), reported the sale of 4,000 shares of common stock.
  • The transactions occurred on November 3, 2025.
  • The shares were sold in two separate transactions: 2,000 shares at a weighted average price of $200.1368 per share and 2,000 shares at a price of $200 per share.
  • The total value of the shares sold is approximately $800,273.60.
  • The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Sheena on June 7, 2024.
  • Following these transactions, Mr. Sheena directly beneficially owns 235,730 shares of Natera Common Stock.
  • Additionally, 26,032 shares are held indirectly by Caraluna 1 Trust and 26,032 shares by Caraluna 2 Trust, for which Mr. Sheena disclaims beneficial ownership.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reports a pre-planned insider sale under a 10b5-1 plan, which is a routine event for personal financial management and does not typically signal a change in company fundamentals or outlook.

Positives

  • The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction not based on immediate, non-public information, which can reduce concerns about opportunistic insider selling.

Negatives

  • An insider sale, even if pre-planned, reduces the reporting person's equity stake in the company, which can sometimes be perceived as a slight reduction in confidence, though mitigated by the 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This insider transaction report reflects a routine, pre-scheduled sale of shares by a co-founder and director. Such transactions are common across industries for personal financial planning and do not inherently indicate a shift in broader industry trends or competitive landscape.

Related Party Transactions

  • The shares were held for the benefit of the beneficiaries of the Caraluna 1 Trust and Caraluna 2 Trust, which are considered related parties to the reporting person.

Stakeholder Impact

  • Shareholders: The sale represents a minor reduction in a co-founder's overall stake, but the pre-planned nature mitigates concerns about market timing.
  • Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this insider transaction.

Key Dates

DateDescription
June 7, 2024Date the Rule 10b5-1 trading plan was adopted by Jonathan Sheena.
November 3, 2025Date of the reported common stock transactions.
November 4, 2025Date the Form 4 was signed by Vincent Fontanilla, Attorney-in-Fact.

Keywords

Natera, NTRA, Jonathan Sheena, Insider Sale, Form 4, 10b5-1 Plan, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.